{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:30:31Z","timestamp":1790803831660,"version":"4.1.0"},"reference-count":203,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.resinv.2024.03.006","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T09:00:46Z","timestamp":1711962046000},"page":"465-480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Relationship between idiopathic interstitial pneumonias (IIPs) and connective tissue disease-related interstitial lung disease (CTD-ILD): A narrative review"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3187-4264","authenticated-orcid":false,"given":"Noriyuki","family":"Enomoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2024.03.006_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.resinv.2014.11.001","article-title":"A prospective survey of idiopathic interstitial pneumonias in a web registry in Japan","volume":"53","author":"Bando","year":"2015","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2024.03.006_bib2","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.chest.2016.11.003","article-title":"Interstitial lung disease in the elderly","volume":"151","author":"Patterson","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.03.006_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/thoraxjnl-2020-216263","article-title":"Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias","volume":"77","author":"Enomoto","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2024.03.006_bib4","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib5","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0140-6736(21)01826-2","article-title":"Treatment of fibrotic interstitial lung disease: current approaches and future directions","volume":"398","author":"Johannson","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.resinv.2024.03.006_bib6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(12)61079-4","article-title":"Interstitial lung disease in connective tissue disorders","volume":"380","author":"Fischer","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2024.03.006_bib7","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1164\/rccm.200402-147OC","article-title":"Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?","volume":"170","author":"Flaherty","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib9","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.rmed.2016.05.030","article-title":"Nonspecific interstitial pneumonia preceding diagnosis of collagen vascular disease","volume":"117","author":"Kono","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106201","article-title":"Clinical, radiological, and pathological evaluation of \"NSIP with OP overlap\" pattern compared with NSIP in patients with idiopathic interstitial pneumonias","volume":"174","author":"Enomoto","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib12","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/rheumatology\/keq410","article-title":"Comparison between cryptogenic organizing pneumonia and connective tissue disease-related organizing pneumonia","volume":"50","author":"Yoo","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2024.03.006_bib13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.chest.2021.12.659","article-title":"Algorithmic approach to the diagnosis of organizing pneumonia: a correlation of clinical, radiologic, and pathologic features","volume":"162","author":"Cherian","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.03.006_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02243-2018","article-title":"Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion","volume":"53","author":"Fujisawa","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1164\/rccm.201403-0566OC","article-title":"Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences","volume":"190","author":"Natsuizaka","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib16","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1183\/09031936.00077309","article-title":"Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology","volume":"35","author":"Vancheri","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094775","article-title":"Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis","volume":"9","author":"Kono","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2024.03.006_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.rmed.2019.06.016","article-title":"Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias","volume":"154","author":"Katsumata","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib20","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1378\/chest.09-0444","article-title":"Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern","volume":"136","author":"Kim","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.03.006_bib21","first-page":"235","article-title":"Nonspecific interstitial pneumonia in collagen vascular diseases: comparison of the clinical characteristics and prognostic significance with usual interstitial pneumonia, Sarcoidosis Vasc Diffuse Lung","volume":"20","author":"Nakamura","year":"2003","journal-title":"Dis"},{"key":"10.1016\/j.resinv.2024.03.006_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1378\/chest.130.1.22","article-title":"Quantitative analysis of fibroblastic foci in usual interstitial pneumonia","volume":"130","author":"Enomoto","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.03.006_bib23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1164\/rccm.200607-912OC","article-title":"Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes","volume":"175","author":"Park","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib24","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/09031936.00019210","article-title":"Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome","volume":"37","author":"Tsuchiya","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib25","doi-asserted-by":"crossref","unstructured":"Graney B.A., Fischer A. Interstitial pneumonia with autoimmune features. Ann Am Thorac Soc 2019; 16 (5): 525\u2013533.","DOI":"10.1513\/AnnalsATS.201808-565CME"},{"key":"10.1016\/j.resinv.2024.03.006_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.rmed.2018.02.024","article-title":"Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia","volume":"137","author":"Yoshimura","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib27","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s10067-018-4111-5","article-title":"Clinical features, risk factors, and outcomes of patients with interstitial pneumonia with autoimmune features: a population-based study","volume":"37","author":"Dai","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.resinv.2024.03.006_bib28","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet."},{"key":"10.1016\/j.resinv.2024.03.006_bib29","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1164\/rccm.201810-1947OC","article-title":"Poor concordance between sequential transbronchial lung cryobiopsy and surgical lung biopsy in the diagnosis of diffuse interstitial lung diseases","volume":"199","author":"Romagnoli","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib30","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1164\/rccm.202209-1812OC","article-title":"Transbronchial lung cryobiopsy and surgical lung biopsy: a prospective multi-centre agreement clinical trial (CAN-ICE)","volume":"207","author":"Fortin","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib31","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S2213-2600(20)30122-3","article-title":"Prognostic value of transbronchial lung cryobiopsy for the multidisciplinary diagnosis of idiopathic pulmonary fibrosis: a retrospective validation study","volume":"8","author":"Tomassetti","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S2213-2600(19)30342-X","article-title":"Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study","volume":"8","author":"Troy","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1164\/rccm.201504-0711OC","article-title":"Bronchoscopic lung cryobiopsy increases diagnostic confidence in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis","volume":"193","author":"Tomassetti","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S2213-2600(19)30059-1","article-title":"Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study","volume":"7","author":"Raghu","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1164\/rccm.202003-0877OC","article-title":"Utility of a molecular classifier as a complement to high-resolution computed tomography to identify usual interstitial pneumonia","volume":"203","author":"Richeldi","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib36","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S2213-2600(16)30033-9","article-title":"Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study","volume":"4","author":"Walsh","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib37","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.chest.2018.03.026","article-title":"Diagnostic ability of a dynamic multidisciplinary discussion in interstitial lung diseases: a retrospective observational study of 938 cases","volume":"153","author":"De Sadeleer","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.03.006_bib38","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02465-2018","article-title":"Probable usual interstitial pneumonia pattern on chest CT: is it sufficient for a diagnosis of idiopathic pulmonary fibrosis?","volume":"55","author":"Fukihara","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1164\/rccm.202111-2607PP","article-title":"Integrating clinical probability into the diagnostic approach to idiopathic pulmonary fibrosis: an international working group perspective","volume":"206","author":"Cottin","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib40","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00936-2017","article-title":"Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study","volume":"50","author":"Walsh","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib41","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib42","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib43","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.rmed.2013.08.008","article-title":"Amount of elastic fibers predicts prognosis of idiopathic pulmonary fibrosis","volume":"107","author":"Enomoto","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib44","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","article-title":"A common MUC5B promoter polymorphism and pulmonary fibrosis","volume":"364","author":"Seibold","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib45","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/resp.12466","article-title":"MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis","volume":"20","author":"Horimasu","year":"2015","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2024.03.006_bib46","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1164\/rccm.201505-1010OC","article-title":"TOLLIP, MUC5B, and the response to N-acetylcysteine among individuals with idiopathic pulmonary fibrosis","volume":"192","author":"Oldham","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95869-9","article-title":"Association of rs3750920 polymorphism in TOLLIP with clinical characteristics of fibrosing interstitial lung diseases in Japanese","volume":"11","author":"Isshiki","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2024.03.006_bib48","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1164\/rccm.201809-1646OC","article-title":"Telomere length and use of immunosuppressive medications in idiopathic pulmonary fibrosis","volume":"200","author":"Newton","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib49","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","article-title":"Clinical course and prediction of survival in idiopathic pulmonary fibrosis","volume":"183","author":"Ley","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib50","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1183\/13993003.01537-2014","article-title":"Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction","volume":"46","author":"Raghu","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib51","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1378\/chest.129.3.746","article-title":"Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis","volume":"129","author":"Lettieri","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.03.006_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94907-w","article-title":"Diagnostic and prognostic significance of serum angiopoietin-1 and -2 concentrations in patients with pulmonary hypertension","volume":"11","author":"Enomoto","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2024.03.006_bib53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.rmed.2016.03.001","article-title":"Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis","volume":"114","author":"Uehara","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib54","article-title":"Pulmonary arterial hypertension: pathogenesis and clinical management","volume":"360","author":"Thenappan","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.resinv.2024.03.006_bib55","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Raghu","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib56","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1164\/rccm.201503-0562OC","article-title":"Efficacy of nintedanib in idiopathic pulmonary fibrosis across prespecified subgroups in INPULSIS","volume":"193","author":"Costabel","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib57","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S2213-2600(18)30339-4","article-title":"Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON","volume":"7","author":"Crestani","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib58","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12931-019-1161-4","article-title":"Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat","volume":"20","author":"Maher","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2024.03.006_bib59","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1513\/AnnalsATS.201810-720RL","article-title":"Pirfenidone treatment in individuals with idiopathic pulmonary fibrosis: impact of timing of treatment initiation","volume":"16","author":"Maher","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.resinv.2024.03.006_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106722","article-title":"Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort study","volume":"191","author":"Adams","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib61","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/resp.13145","article-title":"Body size-adjusted dose analysis of pirfenidone in patients with interstitial pneumonia","volume":"23","author":"Uehara","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2024.03.006_bib62","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1164\/rccm.200611-1685OC","article-title":"Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project","volume":"177","author":"Travis","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib63","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.resinv.2021.04.011","article-title":"2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease","volume":"59","author":"Kondoh","year":"2021","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2024.03.006_bib64","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1148\/radiol.0990898","article-title":"Biopsy-proved idiopathic pulmonary fibrosis: spectrum of nondiagnostic thin-section CT diagnoses","volume":"254","author":"Sverzellati","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.resinv.2024.03.006_bib65","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1148\/radiol.14130853","article-title":"Pathologically proved nonspecific interstitial pneumonia: CT pattern analysis as compared with usual interstitial pneumonia CT pattern","volume":"272","author":"Sumikawa","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.resinv.2024.03.006_bib66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejrad.2007.12.006","article-title":"Nonspecific interstitial pneumonia: histologic correlation with high-resolution CT in 29 patients","volume":"70","author":"Sumikawa","year":"2009","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.resinv.2024.03.006_bib67","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1148\/radiol.2251011555","article-title":"Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patients","volume":"225","author":"Johkoh","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.resinv.2024.03.006_bib68","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/1471-2466-14-175","article-title":"Nonspecific interstitial pneumonia: clinical associations and outcomes","volume":"14","author":"Xu","year":"2014","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib69","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12931-020-01487-w","article-title":"Usefulness of surgical lung biopsies after cryobiopsies when pathological results are inconclusive or show a pattern suggestive of a nonspecific interstitial pneumonia","volume":"21","author":"Bondue","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2024.03.006_bib70","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/his.12761","article-title":"Organizing pneumonia components in non-specific interstitial pneumonia (NSIP): a clinicopathological study of 33 NSIP cases","volume":"68","author":"Huo","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.resinv.2024.03.006_bib71","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1183\/09031936.00158507","article-title":"Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia","volume":"33","author":"Park","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib72","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/RTI.0000000000000317","article-title":"Short-term automated quantification of radiologic changes in the characterization of idiopathic pulmonary fibrosis versus nonspecific interstitial pneumonia and prediction of long-term survival","volume":"33","author":"De Giacomi","year":"2018","journal-title":"J Thorac Imag"},{"key":"10.1016\/j.resinv.2024.03.006_bib73","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/RCT.0b013e31822a5883","article-title":"Nonspecific interstitial pneumonia: prognostic significance of high-resolution computed tomography in 59 patients","volume":"35","author":"Hozumi","year":"2011","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.resinv.2024.03.006_bib74","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00545-2018","article-title":"Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumonia","volume":"52","author":"King","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib75","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00296-005-0028-9","article-title":"Non-specific interstitial pneumonia; as the first clinical presentation of various collagen vascular disorders","volume":"26","author":"Sato","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.resinv.2024.03.006_bib76","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12931-017-0686-7","article-title":"Factors affecting treatment outcome in patients with idiopathic nonspecific interstitial pneumonia: a nationwide cohort study","volume":"18","author":"Lee","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2024.03.006_bib77","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJMra2116777","article-title":"Cryptogenic organizing pneumonia","volume":"386","author":"King","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib78","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2214\/ajr.162.3.8109493","article-title":"Cryptogenic organizing pneumonia: CT findings in 43 patients","volume":"162","author":"Lee","year":"1994","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.resinv.2024.03.006_bib79","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2214\/AJR.09.3940","article-title":"Cryptogenic organizing pneumonia: serial high-resolution CT findings in 22 patients","volume":"195","author":"Lee","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.resinv.2024.03.006_bib80","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1590\/S1806-37132015000004544","article-title":"Organizing pneumonia: chest HRCT findings","volume":"41","author":"Faria","year":"2015","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.resinv.2024.03.006_bib81","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2214\/ajr.180.5.1801251","article-title":"Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications","volume":"180","author":"Kim","year":"2003","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.resinv.2024.03.006_bib82","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.ejrad.2016.05.012","article-title":"Antisynthetase syndrome: pulmonary computed tomography findings of adult patients with antibodies to aminoacyl-tRNA synthetases","volume":"85","author":"Waseda","year":"2016","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.resinv.2024.03.006_bib83","article-title":"Clinical and radiological features of interstitial lung diseases associated with polymyositis and dermatomyositis","volume":"58","author":"Palmucci","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.resinv.2024.03.006_bib84","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1038\/s41598-019-43782-7","article-title":"Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre study","volume":"9","author":"Enomoto","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2024.03.006_bib85","first-page":"11230","article-title":"Nonspecific interstitial pneumonia overlaps organizing pneumonia in lung-dominant connective tissue disease","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.resinv.2024.03.006_bib86","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/jclinpath-2012-201342","article-title":"Fibrosing organising pneumonia","volume":"66","author":"Beardsley","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.resinv.2024.03.006_bib87","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2169\/internalmedicine.56.7371","article-title":"A cryptogenic case of fulminant fibrosing organizing pneumonia","volume":"56","author":"Kobayashi","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib88","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/his.14427","article-title":"Cicatricial organising pneumonia associated with fibrosing interstitial pneumonia - a clinicopathological study","volume":"80","author":"Zaizen","year":"2022","journal-title":"Histopathology."},{"key":"10.1016\/j.resinv.2024.03.006_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206186","article-title":"Proposed method of histological separation between connective tissue disease-associated interstitial pneumonia and idiopathic interstitial pneumonias","volume":"13","author":"Ozasa","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2024.03.006_bib90","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/his.12415","article-title":"Prognostic relevance of histological variants in nonspecific interstitial pneumonia","volume":"65","author":"Kambouchner","year":"2014","journal-title":"Histopathology."},{"key":"10.1016\/j.resinv.2024.03.006_bib91","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1007\/s10067-018-4289-6","article-title":"A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjogren's syndrome-related interstitial lung disease in a Chinese population","volume":"37","author":"Dong","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.resinv.2024.03.006_bib92","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.rmed.2015.09.015","article-title":"Organizing pneumonia\/non-specific interstitial pneumonia overlap is associated with unfavorable lung disease progression","volume":"109","author":"Todd","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib93","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/modpathol.2008.56","article-title":"Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity?","volume":"21","author":"Becker","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.resinv.2024.03.006_bib94","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.resinv.2012.06.003","article-title":"Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis","volume":"50","author":"Watanabe","year":"2012","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2024.03.006_bib95","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2466-14-91","article-title":"Quantitative analysis of lung elastic fibers in idiopathic pleuroparenchymal fibroelastosis (IPPFE): comparison of clinical, radiological, and pathological findings with those of idiopathic pulmonary fibrosis (IPF)","volume":"14","author":"Enomoto","year":"2014","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib96","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2466-12-72","article-title":"Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients","volume":"12","author":"Kusagaya","year":"2012","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2017.11.003","article-title":"Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: a retrospective multicenter study","volume":"133","author":"Enomoto","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib98","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1378\/chest.126.6.2007","article-title":"Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity","volume":"126","author":"Frankel","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.03.006_bib99","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.resinv.2019.02.007","article-title":"Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: a proposal","volume":"57","author":"Watanabe","year":"2019","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2024.03.006_bib100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.rmed.2016.12.013","article-title":"Evaluation of urinary desmosines as a noninvasive diagnostic biomarker in patients with idiopathic pleuroparenchymal fibroelastosis (PPFE)","volume":"123","author":"Oyama","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejro.2020.100298","article-title":"Pleuroparenchymal fibroelastosis-like lesions in patients with interstitial pneumonia diagnosed by multidisciplinary discussion with surgical lung biopsy","volume":"7","author":"Sumikawa","year":"2020","journal-title":"Eur J Radiol Open"},{"key":"10.1016\/j.resinv.2024.03.006_bib102","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/thorax-2022-219116","article-title":"Prognostic significance of radiological pleuroparenchymal fibroelastosis in Mycobacterium avium complex lung disease: a multicentre retrospective cohort study","volume":"78","author":"Aono","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2024.03.006_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180283","article-title":"Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease","volume":"12","author":"Enomoto","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2024.03.006_bib104","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1093\/rheumatology\/keaa451","article-title":"Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review","volume":"59","author":"Orlandi","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2024.03.006_bib105","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02135-2019","article-title":"Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact","volume":"56","author":"Bonifazi","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib106","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1378\/chest.103.6.1808","article-title":"Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases","volume":"103","author":"Kondoh","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.03.006_bib107","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","article-title":"Acute exacerbations of idiopathic pulmonary fibrosis","volume":"176","author":"Collard","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib108","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report","volume":"194","author":"Collard","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib109","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1465-9921-14-86","article-title":"Acute exacerbations in patients with idiopathic pulmonary fibrosis","volume":"14","author":"Kim","year":"2013","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2024.03.006_bib110","first-page":"103","article-title":"Risk factors of acute exacerbation of idiopathic pulmonary fibrosis","volume":"27","author":"Kondoh","year":"2010","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.resinv.2024.03.006_bib111","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1183\/09031936.00159709","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome","volume":"37","author":"Song","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib112","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejim.2007.04.024","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: a systematic review","volume":"19","author":"Agarwal","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib113","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01339-2016","article-title":"Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis","volume":"49","author":"Collard","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib114","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12931-016-0400-1","article-title":"Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis","volume":"17","author":"Kakugawa","year":"2016","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2024.03.006_bib115","doi-asserted-by":"crossref","DOI":"10.1177\/1479972318809476","article-title":"Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis","volume":"16","author":"Enomoto","year":"2019","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.resinv.2024.03.006_bib116","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1183\/09031936.06.00114004","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features","volume":"27","author":"Kim","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib117","doi-asserted-by":"crossref","DOI":"10.1177\/1753466620935774","article-title":"Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis","volume":"14","author":"Enomoto","year":"2020","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.resinv.2024.03.006_bib118","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1378\/chest.07-0323","article-title":"Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis","volume":"132","author":"Park","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.03.006_bib119","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.rmed.2008.12.019","article-title":"Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases","volume":"103","author":"Suda","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib120","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s12890-022-02197-3","article-title":"Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases","volume":"22","author":"Enomoto","year":"2022","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib121","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12931-022-01978-y","article-title":"Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model","volume":"23","author":"Hozumi","year":"2022","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2024.03.006_bib122","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.resinv.2021.06.007","article-title":"COVID-19 and acute exacerbation of interstitial lung disease","volume":"59","author":"Kondoh","year":"2021","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2024.03.006_bib123","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1164\/rccm.202112-2765LE","article-title":"COVID-19 vaccine in patients with exacerbation of idiopathic pulmonary fibrosis","volume":"206","author":"Sgalla","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib124","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1164\/rccm.200709-1365OC","article-title":"Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis","volume":"178","author":"Akira","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2214\/ajr.168.1.8976924","article-title":"CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis","volume":"168","author":"Akira","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.resinv.2024.03.006_bib126","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41598-022-05138-6","article-title":"New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis","volume":"12","author":"Sakamoto","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2024.03.006_bib127","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.resinv.2021.05.008","article-title":"Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis","volume":"59","author":"Tanaka","year":"2021","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2024.03.006_bib128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12931-014-0109-y","article-title":"Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis","volume":"15","author":"Oda","year":"2014","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2024.03.006_bib129","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315027","article-title":"Pathological roles of pulmonary cells in acute lung injury: lessons from clinical practice","volume":"23","author":"Enomoto","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.resinv.2024.03.006_bib130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000287232","article-title":"Neutrophil adsorption by polymyxin B-immobilized fiber column for acute exacerbation in patients with interstitial pneumonia: a pilot study","volume":"29","author":"Abe","year":"2010","journal-title":"Blood Purif"},{"key":"10.1016\/j.resinv.2024.03.006_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106534","article-title":"Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease","volume":"186","author":"Kono","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116775","article-title":"Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis","volume":"10","author":"Schupp","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2024.03.006_bib133","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1111\/crj.12918","article-title":"Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis","volume":"12","author":"Enomoto","year":"2018","journal-title":"Clin Res J"},{"key":"10.1016\/j.resinv.2024.03.006_bib134","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/916486","article-title":"Gradual increase of high mobility group protein b1 in the lungs after the onset of acute exacerbation of idiopathic pulmonary fibrosis","volume":"2011","author":"Ebina","year":"2011","journal-title":"Pulm Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib135","doi-asserted-by":"crossref","first-page":"L3","DOI":"10.1152\/ajplung.90637.2008","article-title":"Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis","volume":"299","author":"Collard","year":"2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.resinv.2024.03.006_bib136","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000330325","article-title":"Reduction in serum high mobility group box-1 level by polymyxin B-immobilized fiber column in patients with idiopathic pulmonary fibrosis with acute exacerbation","volume":"32","author":"Abe","year":"2011","journal-title":"Blood Purif"},{"key":"10.1016\/j.resinv.2024.03.006_bib137","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/resp.13634","article-title":"Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis","volume":"25","author":"Yamaguchi","year":"2020","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2024.03.006_bib138","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46990-3","article-title":"Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis","volume":"9","author":"Enomoto","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2024.03.006_bib139","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/resp.13065","article-title":"High-dose prednisolone after intravenous methylprednisolone improves prognosis of acute exacerbation in idiopathic interstitial pneumonias","volume":"22","author":"Arai","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2024.03.006_bib140","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12931-022-02195-3","article-title":"Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis","volume":"23","author":"Anan","year":"2022","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2024.03.006_bib141","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S2213-2600(21)00354-4","article-title":"Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"10","author":"Naccache","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib142","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1164\/rccm.201909-1818OC","article-title":"Thrombomodulin alfa for acute exacerbation of idiopathic pulmonary fibrosis. A randomized, double-blind placebo-controlled trial","volume":"201","author":"Kondoh","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib143","article-title":"Antifibrotic treatment improves clinical outcomes in patients with idiopathic pulmonary fibrosis: a propensity score matching analysis","volume":"10","author":"Kang","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2024.03.006_bib144","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.rmed.2016.02.001","article-title":"Nintedanib in patients with idiopathic pulmonary fibrosis: combined evidence from the TOMORROW and INPULSIS((R)) trials","volume":"113","author":"Richeldi","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib145","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2169\/internalmedicine.51.6965","article-title":"Polymyxin B-immobilized fiber column (PMX) treatment for idiopathic pulmonary fibrosis with acute exacerbation: a multicenter retrospective analysis","volume":"51","author":"Abe","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib146","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1440-1843.2008.01290.x","article-title":"Possible therapeutic effect of direct haemoperfusion with a polymyxin B immobilized fibre column (PMX-DHP) on pulmonary oxygenation in acute exacerbations of interstitial pneumonia","volume":"13","author":"Enomoto","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2024.03.006_bib147","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000320128","article-title":"Evaluation of different perfusion durations in direct hemoperfusion with polymyxin B-immobilized fiber column therapy for acute exacerbation of interstitial pneumonias","volume":"32","author":"Kono","year":"2011","journal-title":"Blood Purif"},{"key":"10.1016\/j.resinv.2024.03.006_bib148","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12890-015-0004-4","article-title":"Treatment of acute exacerbation of idiopathic pulmonary fibrosis with direct hemoperfusion using a polymyxin B-immobilized fiber column improves survival","volume":"15","author":"Enomoto","year":"2015","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib149","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.2169\/internalmedicine.55.6056","article-title":"Survival from an acute exacerbation of idiopathic pulmonary fibrosis with or without direct hemoperfusion with a polymyxin B-immobilized fiber column: a retrospective analysis","volume":"55","author":"Oishi","year":"2016","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib150","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/resp.13054","article-title":"Direct hemoperfusion with polymyxin B-immobilized fibre treatment for acute exacerbation of interstitial pneumonia","volume":"22","author":"Furusawa","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2024.03.006_bib151","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0210-2022","article-title":"Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis","volume":"32","author":"Joy","year":"2023","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.resinv.2024.03.006_bib152","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1164\/rccm.201903-0486OC","article-title":"Tracking impact of interstitial lung disease in systemic sclerosis in a complete nationwide cohort","volume":"200","author":"Hoffmann-Vold","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib153","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13075-018-1804-8","article-title":"New-onset non-infectious pulmonary manifestations among patients with systemic lupus erythematosus in Sweden","volume":"21","author":"Forbess","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.resinv.2024.03.006_bib154","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib155","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02026-2019","article-title":"Predictors of progression in systemic sclerosis patients with interstitial lung disease","volume":"55","author":"Distler","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib156","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/art.41153","article-title":"Using autoantibodies and cutaneous subset to develop outcome-based disease classification in systemic sclerosis","volume":"72","author":"Nihtyanova","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.resinv.2024.03.006_bib157","first-page":"69","volume":"vol. 5","author":"Ghirardello","year":"2014"},{"key":"10.1016\/j.resinv.2024.03.006_bib158","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/08916930600622884","article-title":"Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies","volume":"39","author":"Yoshifuji","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.resinv.2024.03.006_bib159","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/art.22506","article-title":"Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase","volume":"56","author":"Hirakata","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2024.03.006_bib160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120313","article-title":"Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis\/dermatomyositis-associated interstitial lung disease: a retrospective case control study","volume":"10","author":"Hozumi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2024.03.006_bib161","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.rmed.2016.10.019","article-title":"Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease","volume":"121","author":"Hozumi","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib162","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.amjms.2017.07.013","article-title":"Clinical heterogeneity of interstitial lung disease in polymyositis and dermatomyositis patients with or without specific autoantibodies","volume":"355","author":"Chen","year":"2018","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.resinv.2024.03.006_bib163","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/rheumatology\/keq153","article-title":"Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis","volume":"49","author":"Hoshino","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2024.03.006_bib164","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/rheumatology\/ker518","article-title":"The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM","volume":"51","author":"Koga","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2024.03.006_bib165","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001202","article-title":"Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease","volume":"6","author":"Nishina","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.resinv.2024.03.006_bib166","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/rheumatology\/kep375","article-title":"The RIG-I-like receptor IFIH1\/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody","volume":"49","author":"Nakashima","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2024.03.006_bib167","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.rmed.2013.01.014","article-title":"The prognostic value of HRCT in myositis-associated interstitial lung disease","volume":"107","author":"Tanizawa","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib168","doi-asserted-by":"crossref","first-page":"309","DOI":"10.55563\/clinexprheumatol\/8xj0b9","article-title":"Defining anti-synthetase syndrome: a systematic literature review","volume":"40","author":"Zanframundo","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.resinv.2024.03.006_bib169","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1183\/09031936.06.00038806","article-title":"Interstitial lung diseases associated with amyopathic dermatomyositis","volume":"28","author":"Suda","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib170","first-page":"58","article-title":"Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis","volume":"32","author":"Fujisawa","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.resinv.2024.03.006_bib171","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.rmed.2012.09.005","article-title":"Pulmonary manifestations of anti-ARS antibody positive interstitial pneumonia--with or without PM\/DM","volume":"107","author":"Takato","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib172","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejrad.2018.08.005","article-title":"Radiological images of interstitial pneumonia in mixed connective tissue disease compared with scleroderma and polymyositis\/dermatomyositis","volume":"107","author":"Yamanaka","year":"2018","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.resinv.2024.03.006_bib173","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040465","article-title":"Systematic review and meta-analysis of the risk of rheumatoid arthritis-associated interstitial lung disease related to anti-cyclic citrullinated peptide (CCP) antibody","volume":"11","author":"Kamiya","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.resinv.2024.03.006_bib174","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2559.2004.01896.x","article-title":"Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis","volume":"44","author":"Tansey","year":"2004","journal-title":"Histopathology."},{"key":"10.1016\/j.resinv.2024.03.006_bib175","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1378\/chest.10-0194","article-title":"Connective tissue disease-associated interstitial lung disease: a call for clarification","volume":"138","author":"Fischer","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.03.006_bib176","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/resp.12728","article-title":"Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias","volume":"21","author":"van der Vis","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2024.03.006_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152098","article-title":"Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease","volume":"57","author":"Wheeler","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.resinv.2024.03.006_bib178","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib179","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2024.03.006_bib180","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3899\/jrheum.101002","article-title":"Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan","volume":"38","author":"Yamasaki","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.resinv.2024.03.006_bib181","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13075-018-1776-8","article-title":"Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort","volume":"20","author":"Narvaez","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.resinv.2024.03.006_bib182","doi-asserted-by":"crossref","first-page":"9184","DOI":"10.1038\/s41598-021-88734-2","article-title":"Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis","volume":"11","author":"Cano-Jimenez","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2024.03.006_bib183","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1080\/03007995.2019.1647040","article-title":"Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management","volume":"35","author":"Wijsenbeek","year":"2019","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.resinv.2024.03.006_bib184","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/rheumatology\/keab552","article-title":"The attitudes and practices of physicians caring for patients with rheumatoid arthritis-associated interstitial lung disease: an international survey","volume":"61","author":"Solomon","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2024.03.006_bib185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/17476348.2023.2176303","article-title":"Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements","volume":"17","author":"Kuwana","year":"2023","journal-title":"Expet Rev Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib186","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/03009741003604542","article-title":"Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA","volume":"39","author":"Nakajima","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.resinv.2024.03.006_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106898","article-title":"Clinical features of acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: comparison with idiopathic pulmonary fibrosis","volume":"200","author":"Otsuka","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib188","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098824","article-title":"Prognostic factors for myositis-associated interstitial lung disease","volume":"9","author":"Fujisawa","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2024.03.006_bib189","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1067\/mjd.2002.120621","article-title":"Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?","volume":"46","author":"Sontheimer","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.resinv.2024.03.006_bib190","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","article-title":"Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2024.03.006_bib191","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/rheumatology\/kes012","article-title":"Hyperferritinaemia and macrophage activation in a patient with interstitial lung disease with clinically amyopathic DM","volume":"51","author":"Gono","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2024.03.006_bib192","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib193","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00894-2020","article-title":"Progressive fibrosing interstitial lung disease: we know it behaves badly, but what does that mean?","volume":"55","author":"Wongkarnjana","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib194","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.rmed.2015.08.010","article-title":"Survival in interstitial pneumonia with features of autoimmune disease: a comparison of proposed criteria","volume":"109","author":"Assayag","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib195","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.rmed.2019.03.011","article-title":"Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients","volume":"150","author":"Sambataro","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib196","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01205-2020","article-title":"Myositis-specific antibodies identify a distinct interstitial pneumonia with autoimmune features phenotype","volume":"56","author":"Graham","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib197","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02519-2017","article-title":"Cyclophosphamide in steroid refractory unclassifiable idiopathic interstitial pneumonia and interstitial pneumonia with autoimmune features (IPAF)","volume":"51","author":"Wiertz","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107500","article-title":"Characteristics and risk factors of interstitial pneumonia with autoimmune features","volume":"221","author":"Vahidy","year":"2024","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib199","doi-asserted-by":"crossref","first-page":"560","DOI":"10.55563\/clinexprheumatol\/off5n7","article-title":"The role of pirfenidone in the treatment of interstitial pneumonia with autoimmune features","volume":"40","author":"Chen","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.resinv.2024.03.006_bib200","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.03.006_bib201","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003487","article-title":"Efficacy of non-conventional synthetic DMARDs for patients with rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis","volume":"9","author":"Yuan","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.resinv.2024.03.006_bib202","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00337-2020","article-title":"Methotrexate and rheumatoid arthritis associated interstitial lung disease","volume":"57","author":"Juge","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.03.006_bib203","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.resinv.2023.01.003","article-title":"Clinical features of idiopathic pleuroparenchymal fibroelastosis with progressive phenotype showing a decline in forced vital capacity","volume":"61","author":"Kono","year":"2023","journal-title":"Respir Investig"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524000480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524000480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T15:49:26Z","timestamp":1714319366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534524000480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":203,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2212534524000480"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2024.03.006","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between idiopathic interstitial pneumonias (IIPs) and connective tissue disease-related interstitial lung disease (CTD-ILD): A narrative review","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2024.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}